Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Frequency of thyroid dysfunction in diabetic patients: value of annual screening.

Perros P, McCrimmon RJ, Shaw G, Frier BM.

Diabet Med. 1995 Jul;12(7):622-7.

PMID:
7554786
2.
3.

[Ultrasensitive TSH screening for detection of thyroid gland dysfunctions in women of a medical ambulatory care patient group].

Meier C, Staub JJ, Roth CB, Kunz M, Guglielmetti M, Martina B, Huber P.

Schweiz Med Wochenschr. 1998 Feb 14;128(7):250-3. German.

PMID:
9540149
4.
5.

Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan.

Radaideh AR, Nusier MK, Amari FL, Bateiha AE, El-Khateeb MS, Naser AS, Ajlouni KM.

Saudi Med J. 2004 Aug;25(8):1046-50.

PMID:
15322596
6.

Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians.

Helfand M, Redfern CC.

Ann Intern Med. 1998 Jul 15;129(2):144-58. Erratum in: Ann Intern Med 1999 Feb 2;130(3):246.

PMID:
9669977
7.

Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants.

Pirich C, Müllner M, Sinzinger H.

J Clin Epidemiol. 2000 Jun;53(6):623-9.

PMID:
10880781
8.

The prevalence of thyroid dysfunction in a population with borderline iodine deficiency.

Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H.

Clin Endocrinol (Oxf). 1999 Sep;51(3):361-7.

PMID:
10469017
9.

Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study.

Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, Kitabchi AE.

Diabetes Care. 2003 Apr;26(4):1181-5.

PMID:
12663594
10.

Screening for thyroid disorders in asymptomatic adults from Brazilian populations.

Bensenor I.

Sao Paulo Med J. 2002 Sep 2;120(5):146-51. Review.

11.

[Subclinical thyroid disorders].

Krysiak R, Okopień B, Herman ZS.

Pol Merkur Lekarski. 2006 Dec;21(126):573-8. Review. Polish.

PMID:
17405301
12.

Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes.

Araujo J, Brandão LA, Guimarães RL, Santos S, Falcão EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S.

Pediatr Diabetes. 2008 Jul 28;9(4 Pt 1):272-6. doi: 10.1111/j.1399-5448.2008.00394.x. Epub 2008 May 7.

PMID:
18466214
13.

High prevalence of thyroid abnormalities in a Chilean psychiatric outpatient population.

Fardella C, Gloger S, Figueroa R, Santis R, Gajardo C, Salgado C, Barroilhet S, Foradori A.

J Endocrinol Invest. 2000 Feb;23(2):102-6.

PMID:
10800763
14.

Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance.

Wiersinga WM.

Neth J Med. 1995 Apr;46(4):197-204. Review.

PMID:
7760971
15.

Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies.

Kadiyala R, Peter R, Okosieme OE.

Int J Clin Pract. 2010 Jul;64(8):1130-9. doi: 10.1111/j.1742-1241.2010.02376.x. Review.

PMID:
20642711
16.

A study of thyroid function and prevalence of thyroid autoantibodies in an African diabetic population.

Cardoso C, Ohwovoriole AE, KuKu SF.

J Diabetes Complications. 1995 Jan-Mar;9(1):37-41.

PMID:
7734742
17.

Subclinical hyperthyroidism in patients with type 2 diabetes.

Díez JJ, Iglesias P.

Endocrine. 2012 Aug;42(1):157-63. doi: 10.1007/s12020-012-9621-3. Epub 2012 Feb 12.

PMID:
22327927
18.

Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.

Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL, Lin HD.

Diabet Med. 2007 Dec;24(12):1336-44. Epub 2007 Oct 17. Erratum in: Diabet Med. 2008 Feb;25(2):244.

PMID:
17941864
19.

Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.

Rattarasarn C, Diosdado MA, Ortego J, Leelawattana R, Soonthornpun S, Setasuban W, Jaruratanasirikul S, Patarakijvanich N.

Diabetes Res Clin Pract. 2000 Aug;49(2-3):107-11.

PMID:
10963821
20.

Supplemental Content

Support Center